drugset / Trial / NCT02037412

Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome

NCT02037412 ↗

Phase 4 Terminated 148 enrolled Yonsei University
RandomizedParallel-groupOpen-labelTreatment

Summary

The investigators hypothesized that ticagrelor may enhance endothelial healing after DES implantation by increasing adenosine concentrations by the inhibition of adenosine uptake into erythrocytes, compared to clopidogrel. Thus, the investigators will evaluate the extent of endothelialization (stent strut coverage) and neointimal hyperplasia (neointimal thickness) 3 months after DES implantation by optical coherence tomography (OCT)

Timeline

Start
2014-01
Primary completion
2016-09-30
Completion
2016-09-30

Outcome

Outcome not reported

Stopped: “The patient registration was not successful.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 75 mg —
Subject Ticagrelor Small molecule 90 mg —